Skip to main
PRTK
PRTK logo

Paratek Pharma (PRTK)


$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Paratek Pharma (PRTK) Stock

About Paratek Pharma (PRTK)

Paratek Pharmaceuticals, Inc. engages in the development and commercialization of therapies based upon tetracycline chemistry. Its products include omadacycline and sarecycline, which are used for the treatment of community-acquired bacterial infections, including community-acquired bacterial pneumonia, acute bacterial skin and skin structure infections and urinary tract infections. The company wa...read more
Market cap$127.83M
Today's volume
Revenue (TTM)
Avg. daily volume601.92K
EBITDA (TTM)
Open
Price / earnings ratio-2.00x
Today's range
Debt / equity
52 week range$1.29 - $3.65
5 year debt / equity-155.87x
Beta (LTM)1.04x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsAug 3, 2023
Dividend payable date

Frequently Asked Questions (FAQ)

As of Dec 04, 2025, the market cap for PRTK stock is $127.83M

The current P/E ratio for PRTK stock is -2

The 52-week high for PRTK stock is $3.65. The current PRTK stock price $undefined is 100.00% below its 52-week high

The 52-week low for PRTK stock is $1.29. The current PRTK stock price $undefined has increased 100.00% from its 52-week low

No, the PRTK stock does not pay dividends to its shareholders

How to buy PRTK stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in PRTK stock

    Navigate to the Explore page. Then, type PRTK into the search bar. When you see PRTK stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased PRTK stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Paratek Pharma Stock Earnings

The value each PRTK share was expected to gain vs. the value that each PRTK share actually gained.

Paratek Pharma (PRTK) reported Q2 2023 earnings per share (EPS) of -$0.25, beating estimates of -$0.31 by 19.35%. In the same quarter last year, Paratek Pharma's earnings per share (EPS) was -$0.33. Paratek Pharma is expected to release next earnings on 08/03/2023, with an earnings per share (EPS) estimate of $0.

Buy Paratek Pharma (PRTK) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.